针对HCC的个性化医疗方法
Radhika Tippani1, Pallavi Kagithoju1, Ranjith Pabbati2
1Department of Biotechnology, Kakatiya University, Warangal-506009, Telangana, India.
Current pharmaceutical biotechnology
|July 2, 2025
概括
肝细胞癌 (HCC) 的治疗方法有限,需要针对其复杂的分子和代谢途径的新疗法. 个性化医疗方法,包括基于microRNA的疗法,有望改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因,有效治疗方法有限.
- 晚期诊断和多药耐药性阻碍了目前HCC的治疗选择.
- 现有的HCC治疗方法,如氨酸激酶和免疫检查点阻断剂,有效性有限.
研究的目的:
- 对肝细胞癌 (HCC) 的现有和新兴治疗策略进行审查.
- 探索分子标和基于代谢网络的方法,以实现个性化的HCC医学.
- 突出新型疗法的潜力,例如针对HCC的基于microRNA的治疗方法.
主要方法:
- 综合基因组分析,以确定HCC中常见的遗传改变.
- 基因组级代谢建模,以了解癌症特异性代谢.
- 基于microRNA的治疗策略的审查,包括对抗剂和替代疗法.
主要成果:
- 在HCC中,关键的遗传改变包括端粒酶逆转录酶,CTNNB1和TP53.
- 代谢网络分析揭示了基于氧化还原反应和代谢物利用的HCC异质性.
- 基于microRNA的疗法提供了一个有希望的途径,通过向致癌或恢复瘤抑制器miRNAs.
结论:
- 通过了解代谢网络异质性,可以推进针对HCC的个性化药物治疗.
- 基于microRNA的疗法提供了一种新的策略,以克服HCC治疗的局限性.
- 准分子和代谢途径对于开发更有效的HCC疗法至关重要.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
07:25Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
2.0K
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
